ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Avecia builds up drug service business

by Michael McCoy
October 17, 2016 | APPEARED IN VOLUME 94, ISSUE 41

Nitto Denko Avecia will acquire Irvine Pharmaceutical Services, an analytical development services provider, and sister company Avrio Biopharmaceuticals, a contract manufacturer of injectable drugs. Both firms are located in Irvine, Calif. Avecia is a contract manufacturer of oligonucleotides with facilities in Massachusetts and Ohio. President Detlef Rethage says the purchase will broaden Avecia’s services for drug industry customers beyond oligonucleotide manufacturing.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment